文献速递睡眠呼吸障碍慢阻肺

睡眠呼吸障碍中的氧疗:证据与知识缺口

Oxygen Therapy in Sleep-Disordered Breathing.
PubMed 文献 · Chest · 2021-02-19

本文综述夜间补充氧疗(NSO)在睡眠呼吸障碍(SDB)中的疗效。NSO可显著改善OSA患者血氧饱和度,但降低呼吸暂停严重度不如PAP,且可能延长阻塞性呼吸暂停时长;对日间嗜睡效果不明确,对血压影响未定。NSO对心力衰竭相关中枢性睡眠呼吸暂停有效,但对死亡率及心血管结局的影响仍在研究中。

要点

  • NSO改善OSA血氧饱和度但不如PAP降低呼吸暂停严重度,且可能延长阻塞性呼吸暂停。
  • NSO对OSA日间嗜睡效果不明确,可能改善躯体功能相关生活质量,对血压影响未定。
  • NSO对心力衰竭相关中枢性睡眠呼吸暂停有效,对死亡率和心血管结局影响待研究。

核心结论

  • 与假氧疗或PAP相比,OSA及重叠综合征患者氧疗的临床结局研究结论不明确或有限。
  • 氧疗可减轻中枢性睡眠呼吸暂停。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • NSO显著改善OSA患者血氧饱和度,但降低呼吸暂停严重度不如PAP,且可能延长阻塞性呼吸暂停时长。
  • NSO对OSA日间嗜睡效果不明确,可能改善躯体功能相关生活质量。
  • NSO对血压降低效果尚无定论。
  • NSO对OSA合并COPD(重叠综合征)与PAP比较的效果未知。
  • NSO对心力衰竭相关中枢性睡眠呼吸暂停有效,其对死亡率及心血管临床结局的影响正在临床试验中研究。

临床怎么用

  • OSA患者不应以NSO常规替代PAP降低呼吸暂停严重度。
  • 心力衰竭相关中枢性睡眠呼吸暂停可考虑NSO,但需关注心血管结局证据待完善。
  • 重叠综合征患者NSO与PAP比较效果未知,决策需个体化。

局限性

  • 关于OSA和重叠综合征患者氧疗与假氧疗或PAP比较的临床结局研究结论不明确或有限。
  • NSO最佳剂量和疗程及其单独或联合PAP对心血管、睡眠和认知结局的影响尚待研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sleep-disordered breathing (SDB) is highly prevalent in adults and leads to significant cardiovascular and neurologic sequelae. Intermittent hypoxia during sleep is a direct consequence of SDB. Administration of nocturnal supplemental oxygen (NSO) has been used as a therapeutic alternative to positive airway pressure (PAP) in SDB. NSO significantly improves oxygen saturation in OSA but is inferior to PAP in terms of reducing apnea severity and may prolong the duration of obstructive apneas. The effect of NSO on daytime sleepiness remains unclear, but NSO may improve physical function-related quality of life in OSA. Its effects on BP reduction remain inconclusive. The effects of NSO vs PAP in OSA with comorbid COPD (overlap syndrome) are unknown. NSO is effective in reducing central sleep apnea related to congestive heart failure; however, its impact on mortality and cardiovascular clinical outcomes are being investigated in an ongoing clinical trial. In conclusion, studies are inconclusive or limited regarding clinical outcomes with oxygen therapy compared with sham or PAP therapy in patients with OSA and overlap syndrome. Oxygen does mitigate central sleep apnea. This review examines the crucial knowledge gaps and suggests future research priorities to clarify the effects of optimal dose and duration of NSO, alone or in combination with PAP, on cardiovascular, sleep, and cognitive outcomes.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Zeineddine S, Rowley JA, Chowdhuri S, et al. Oxygen Therapy in Sleep-Disordered Breathing. Chest. 2021. PMID: 33610579. doi:10.1016/j.chest.2021.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。